自动调节障碍(为了使心输出量增加,导致血管阻力反射不断增加)[20]Andersson OK, Beckman-Suurkula M, Sannerstedt R, et al. Does hyperkinetic circulation constitute a pre-hypertensive state? J Intern Med. 1989 Dec;226(6):401-8.http://www.ncbi.nlm.nih.gov/pubmed/2489225?tool=bestpractice.com
通过各种机制过量摄入钠[21]Morimoto A, Uzu T, Fujii T, et al. Sodium sensitivity and cardiovascular events in patients with essential hypertension. Lancet. 1997 Dec 13;350(9093):1734-7.http://www.ncbi.nlm.nih.gov/pubmed/9413464?tool=bestpractice.com[22]Weinberger MH. More on the sodium saga. Hypertension. 2004 Nov;44(5):609-11.http://hyper.ahajournals.org/content/44/5/609.fullhttp://www.ncbi.nlm.nih.gov/pubmed/15466665?tool=bestpractice.com
肾的钠潴留[23]Brenner BM, Garcia DL, Anderson S. Glomeruli and blood pressure: less of one, more the other? Am J Hypertens. 1988 Oct;1(4 Pt 1):335-47.http://www.ncbi.nlm.nih.gov/pubmed/3063284?tool=bestpractice.com[24]Blaustein MP. Endogenous ouabain: role in the pathogenesis of hypertension. Kidney Int. 1996 Jun;49(6):1748-53.https://www.kidney-international.org/article/S0085-2538(15)59554-9/pdfhttp://www.ncbi.nlm.nih.gov/pubmed/8743490?tool=bestpractice.com[25]Cowley AW Jr, Roman RJ. The role of the kidney in hypertension. JAMA. 1996 May 22-29;275(20):1581-9.http://www.ncbi.nlm.nih.gov/pubmed/8622250?tool=bestpractice.com[26]Laragh JH. Laragh's lessons in pathophysiology and clinical pearls for treating hypertension. Am J Hypertens. 2001 Jan;14(1):84-9.http://www.ncbi.nlm.nih.gov/pubmed/11206687?tool=bestpractice.com
肾素-血管紧张素-醛固酮轴失调且血浆肾素活性升高[27]Fuchs S, Frenzel K, Xiao HD, et al. Newly recognized physiologic and pathophysiologic actions of the angiotensin-converting enzyme. Curr Hypertens Rep. 2004 Apr;6(2):124-8.http://www.ncbi.nlm.nih.gov/pubmed/15010016?tool=bestpractice.com
交感神经活动度升高[28]Grassi G, Mancia G. Neurogenic hypertension: is the enigma of its origin near its solution? Hypertension. 2004 Feb;43(2):154-5.http://hyper.ahajournals.org/content/43/2/154.fullhttp://www.ncbi.nlm.nih.gov/pubmed/14676221?tool=bestpractice.com
外周阻力增加[29]Schriffin EL. Remodeling of resistance arteries in essential hypertension and the effects of antihypertensive treatment. Am J Hypertens. 2004 Dec;17(12 Pt 1):1192-200.https://academic.oup.com/ajh/article/17/12/1192/155049http://www.ncbi.nlm.nih.gov/pubmed/15607629?tool=bestpractice.com
内皮功能障碍[30]Rossi R, Chiurlia E, Nuzzo A, et al. Flow-mediated vasodilation and the risk of developing hypertension in healthy post-menopausal women. J Am Coll Cardiol. 2004 Oct 19;44(8):1636-40.https://www.sciencedirect.com/science/article/pii/S0735109704015177?via%3Dihubhttp://www.ncbi.nlm.nih.gov/pubmed/15489096?tool=bestpractice.com
细胞膜转运干扰[31]Russo C, Oliveri O, Girelli D, et al. Increased membrane ratios of metabolite to precursor fatty acid in essential hypertension. Hypertension. 1997 Apr;29(4):1058-63.http://hyper.ahajournals.org/content/29/4/1058.fullhttp://www.ncbi.nlm.nih.gov/pubmed/9095099?tool=bestpractice.com
胰岛素抵抗/高胰岛素血症。[32]Sharma AM, Engeli S, Pischon T. New developments in mechanisms of obesity-induced hypertension: role of adipose tissue. Curr Hypertens Rep. 2001 Apr;3(2):152-6.http://www.ncbi.nlm.nih.gov/pubmed/11276398?tool=bestpractice.com